Dr. Gary W. Falk, MD

Dr. Falk practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania.

Dr. Falk's NPI, 1699732537, was assigned on April 26, 2006. Dr. Falk graduated from University of Rochester School of Medicine and Dentistry in 1980. Dr. Falk holds Pennsylvania license MD437142.

Dr. Falk's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 762-0888.

Dr. Falk's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Falk to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Falk practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Falk's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dmand AI has Dr. Falk's licenses on file in 2 states: Pennsylvania and Ohio.

CMS data shows 166 Medicare services from Dr. Falk across 5 procedure codes in 2024, for 167 Medicare patients. Medicare paid $9,870 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 167 Medicare patients who saw Dr. Falk in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Falk's median patient age at 68, with 46% women.

In 2024, Dr. Falk wrote 441 Medicare Part D claims for 128 patients. 81% of them were for generic drugs. CMS names the drug for 396 of them, across 10 drugs with 11 or more claims each, at $46,963 in total drug cost. In 2023, CMS named 557 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Falk for performance year 2024, reported as part of a group.

Dmand AI links 120 papers to Dr. Falk, published from 2015 to 2025. 2022 was the busiest year, with 14. The most frequent topics are Eosinophilic Esophagitis, Esophageal Neoplasms and Barrett Esophagus. Dr. Falk has published most often in Am J Gastroenterol. Dr. Falk's most frequent co-authors are Evan S. Dellon, MD, MPH, Nirmala Gonsalves, MD and Jonathan M. Spergel, MD.

Dmand AI links Dr. Falk to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Eosinophilic Esophagitis, Esophagitis and Barrett Esophagus. Regeneron Pharmaceuticals sponsors the most, 2. Open Payments lists research payments to Dr. Falk that name 3 trials.

CMS Open Payments shows 102 general payments to Dr. Falk from 15 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Sanofi and Genzyme US Companies paid the most, $40,151. It also lists 24 research payments totaling $10,147 from 2016 to 2025, naming 3 clinical trials.

Dr. Falk graduated from University of Rochester School of Medicine and Dentistry in 1980.